Chemclin Diagnostics Co., Ltd. (SHA:688468)
China · Delayed Price · Currency is CNY 6.16
-0.01 (-0.16%)
Aug 4, 2026, 3:00 PM CST
Chemclin Diagnostics Market Cap
Chemclin Diagnostics has a market cap or net worth of 2.43 billion as of August 4, 2026. Its market cap has decreased by -27.44% in one year.
Market Cap
2.43B
Enterprise Value
2.27B
Revenue
324.73M
Ranking
n/a
PE Ratio
67.55
Stock Price
6.16
ChartMarket Cap Chart
Since April 9, 2021, Chemclin Diagnostics's market cap has decreased from 10.00B to 2.43B, a decrease of -75.70%. That is a compound annual growth rate of -23.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 2.43B | -16.08% |
| Dec 31, 2025 | 2.90B | 7.15% |
| Dec 31, 2024 | 2.70B | -37.53% |
| Dec 29, 2023 | 4.33B | 13.94% |
| Dec 30, 2022 | 3.80B | -47.15% |
| Dec 31, 2021 | 7.19B | -28.15% |
| Apr 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Amoy Diagnostics | 6.73B |
| Shanghai Runda Medical Technology | 6.04B |
| Maccura Biotechnology Co.Ltd | 5.50B |
| Cowealth Medical China | 4.10B |
| Shanghai Labway Clinical Laboratory | 3.50B |
| Guangdong Hybribio Biotech | 3.49B |
| Thalys Medical Technology Group | 3.40B |
| Medicalsystem Biotechnology | 3.32B |